Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Archimedes Pharma has launched Lazanda (fentanyl) nasal spray, which provides relief from cancer related pain, in the US pharmacies by prescription.
Subscribe to our email newsletter
Lazanda uses the company’s PecSys drug delivery system, which helps in the rapid absorption of the ingredient across the nasal membrane and directly into the blood stream.
The spray is helpful in the management of pain in cancer patients who are above 18 years of age and are tolerant to opioid therapy.
The efficacy of Lazanda for the management of breakthrough pain in adult cancer patients was demonstrated in a double-blind, placebo-controlled clinical study in patients receiving opioid therapy.
Archimedes Pharma CEO Jeffrey H Buchalter said the availability of Lazanda marks the company’s first product launch in the US and represents the expansion of the brand from Europe.